We are thrilled to share the success of the “Signal to Noise Ratio” event, organized by the Society of Clinical Pharmacy (SSCP) in collaboration with the Saudi Ministry of Health, with support from Carexso. The event, which took place on March 10, 2023, brought together a diverse group of stakeholders, including regulators, providers, patient advocacy groups, payers, and other experts, to focus on rare diseases in Saudi Arabia.

The Standalone aimed to unite all distinguished experts involved in Rare Diseases management to pool competencies and direct attention toward advancing rare diseases end-to-end care in the Kingdom of Saudi Arabia. Key experts rallied for a moonshot program pledge focused on rare diseases, emphasizing the urgent need to improve diagnosis and access to treatments. The discussions were lively and focused on finding innovative ways to tackle the challenges faced by rare disease patients in Saudi Arabia.

At Carexso, we are passionate about improving the lives of rare disease patients by fostering innovation and research in the field. We are proud to have partnered with SSCP and the Saudi Ministry of Health to create a collaborative environment that drives progress in rare disease care. Our goal is to support public-private partnerships that improve outcomes for rare disease patients by driving innovation and enhancing end-to-end rare diseases management ecosystems. We believe that by bringing together stakeholders from across the healthcare ecosystem, we can make significant progress in addressing the challenges faced by rare disease patients.

We are excited to continue convening stakeholders and supporting public-private partnerships that drive innovation and improve outcomes for rare disease patients in Saudi Arabia. Together, we can build on the momentum from the Signal to Noise Ratio event and make a meaningful impact on the rare disease community in Saudi Arabia.